Endometrial cancer is the sixth most common cancer and the fourth leading cause of death amongst women worldwide. Currently there are no screening strategies successfully implemented in clinical practice for the general population. Present diagnostic approaches are invasive, costly and time consuming. Here, we present results of a simple blood test showing promise for endometrial cancer detection. Both Raman and FtIR-ATR (Fourier transform Infrared Attenuated Total Reflection) spectroscopies, of blood plasma taken from patients with and without endometrial cancer, as ascertained by histopathology, are shown to yield discrimination of endometrial cancer. Spectral data classification is performed using Quasar open-source software.
|